ImmunoGen Competitors and Similar CompaniesClear all
ImmunoGen's competitors and similar companies include Ablynx.
 ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. |  Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. | |
Founding Date | Founding Date 1981 | Founding Date 2001 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Waltham, US HQ | Locations Gent, BE HQ |
Employees | Employees 277161% increase | Employees 1252% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $108.8m (FY, 2022) | Revenue (est.) €85.2m (FY, 2016) |
Net income | Net income ($222.9m) (FY, 2022) | Net income (€1.1m) (FY, 2016) |
Funding | ||
Total funding raised | Total funding raised $ 56m | Total funding raised $ 498.8m |
For sources of this data, please see the company profile
View Company Profiles
Ablynx
HQ
Gent, BE
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
View company